News Pharma faces pressure whoever wins Presidential race, warns ... Novartis chief warns on US pricing pressure
News Novartis buys into bispecific antibodies with Xencor deal Agreement could add to Novartis' immuno-oncology pipeline.
News Novartis cancer drugs among raft of NICE recommendations NICE recommends funding for lung cancer and skin cancer treatments.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
